Cargando…

The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model

INTRODUCTION: Management of phenylketonuria (PKU) is mainly achieved through dietary control with limited intake of phenylalanine (Phe) from food, supplemented with low protein (LP) food and a mixture of free synthetic (FS) amino acids (AA) (FSAA). Casein glycomacropeptide (CGMP) is a natural peptid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahring, Kirsten K., Dagnæs-Hansen, Frederik, Brüel, Annemarie, Christensen, Mette, Jensen, Erik, Jensen, Thomas G., Johannsen, Mogens, Johansen, Karen S., Lund, Allan M., Madsen, Jesper G., Brøndum-Nielsen, Karen, Pedersen, Michael, Sørensen, Lambert K., Kjolby, Mads, Møller, Lisbeth B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751992/ https://www.ncbi.nlm.nih.gov/pubmed/35015767 http://dx.doi.org/10.1371/journal.pone.0261150

Ejemplares similares

Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels
por: Ahring, Kirsten K., et al.
Publicado: (2018)

The Use of Glycomacropeptide in Dietary Management of Phenylketonuria
por: Zaki, Osama K., et al.
Publicado: (2016)

The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

A Preclinical Study of Casein Glycomacropeptide as a Dietary Intervention for Acute Mania
por: Liebenberg, Nico, et al.
Publicado: (2018)

The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pena, Maria João, et al.
Publicado: (2018)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021)

Influence of Glycomacropeptide on Rehydration Characteristics of Micellar Casein Concentrate Powder
por: Panthi, Ram R., et al.
Publicado: (2021)

Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
por: Pena, Maria João, et al.
Publicado: (2021)

Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide Diet
por: Solverson, Patrick, et al.
Publicado: (2012)

Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
por: Pinto, A., et al.
Publicado: (2017)

Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial(1)(2)
por: Ney, Denise M, et al.
Publicado: (2016)

Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study
por: Montanari, Chiara, et al.
Publicado: (2022)

Analysis of Bovine Kappa-Casein Glycomacropeptide by Liquid Chromatography–Tandem Mass Spectrometry
por: Qu, Yunyao, et al.
Publicado: (2021)

Cheese Whey Milk Adulteration Determination Using Casein Glycomacropeptide as an Indicator by HPLC
por: Vera-Bravo, Ricardo, et al.
Publicado: (2022)

Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
por: Delsoglio, Marta, et al.
Publicado: (2023)

Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis
por: Cui, Yongbo, et al.
Publicado: (2017)

Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study
por: Qu, Yunyao, et al.
Publicado: (2023)

The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome
por: Qu, Yunyao, et al.
Publicado: (2023)

Antibacterial and Remineralization Efficacy of Casein Phosphopeptide, Glycomacropeptide Nanocomplex, and Probiotics in Experimental Toothpastes: An In Vitro Comparative Study
por: Elgamily, Hanaa, et al.
Publicado: (2019)

Enrichment and Purification of Casein Glycomacropeptide from Whey Protein Isolate Using Supercritical Carbon Dioxide Processing and Membrane Ultrafiltration
por: Bonnaillie, Laetitia M., et al.
Publicado: (2014)

Amino Acid Medical Foods Provide a High Dietary Acid Load and Increase Urinary Excretion of Renal Net Acid, Calcium, and Magnesium Compared with Glycomacropeptide Medical Foods in Phenylketonuria
por: Stroup, Bridget M., et al.
Publicado: (2017)

Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods
por: Stroup, Bridget M., et al.
Publicado: (2017)

Unveiling the Metabolic Effects of Glycomacropeptide
por: Pena, Maria João, et al.
Publicado: (2021)

Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

Multi-Trait Genomic Risk Stratification for Type 2 Diabetes
por: Rohde, Palle Duun, et al.
Publicado: (2021)

Normal RNAi response in human fragile × fibroblasts
por: Madsen, Charlotte, et al.
Publicado: (2009)

Is population screening for abdominal aortic aneurysm cost-effective?
por: Ehlers, Lars, et al.
Publicado: (2008)

Dietary amino acid intakes associated with a low-phenylalanine diet combined with amino acid medical foods and glycomacropeptide medical foods and neuropsychological outcomes in subjects with phenylketonuria
por: Stroup, Bridget M., et al.
Publicado: (2017)

Bi-Allelic Pathogenic Variations in MERTK Including Deletions Are Associated with an Early Onset Progressive Form of Retinitis Pigmentosa
por: Jespersgaard, Cathrine, et al.
Publicado: (2020)

Endotoxin-Binding Peptides Derived from Casein Glycomacropeptide Inhibit Lipopolysaccharide-Stimulated Inflammatory Responses via Blockade of NF-κB activation in macrophages
por: Cheng, Xue, et al.
Publicado: (2015)

Casein Glycomacropeptide Hydrolysates Exert Cytoprotective Effect against Cellular Oxidative Stress by Up-Regulating HO-1 Expression in HepG2 Cells
por: Li, Tiange, et al.
Publicado: (2017)

Effects of casein glycomacropeptide supplementation on growth performance, intestinal morphology, intestinal barrier permeability and inflammatory responses in Escherichia coli K88 challenged piglets
por: Rong, Yili, et al.
Publicado: (2015)

When should social service referral be considered in phenylketonuria?
por: van Rijn, Margreet, et al.
Publicado: (2015)

Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations
por: Sauvé, Mathilde Foisy, et al.
Publicado: (2021)

Glycomacropeptide in PKU—Does It Live Up to Its Potential?
por: Daly, Anne, et al.
Publicado: (2022)

Antidiabetic Effect of Casein Glycomacropeptide Hydrolysates on High-Fat Diet and STZ-Induced Diabetic Mice via Regulating Insulin Signaling in Skeletal Muscle and Modulating Gut Microbiota
por: Yuan, Qichen, et al.
Publicado: (2020)

Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy
por: Jespersgaard, Cathrine, et al.
Publicado: (2019)

Protective Effect of Glycomacropeptide on the Inflammatory Response of U937 Macrophages
por: Córdova-Dávalos, Laura Elena, et al.
Publicado: (2023)

Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Ilgaz, Fatma, et al.
Publicado: (2019)

Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria
por: Zori, Roberto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l8gliql1dvhebqobavui6o6j4k